RAYLIFE INC.

Medtech · Private

needle-free wearable optical device for continuous non-invasive blood glucose monitoring using broadband spectroscopy and physics-informed machine learning

Grants
$305K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Development of Novel Optoelectronics Technology for Non-Invasive, Continuous Blood Glucose Monitoring$304,898
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1351Moleculera Labs, Inc.—$3.4M
1352Seigla Medical, Inc.—$200K
1353BAIRITONE HEALTH INC.—$75K
1354RAYLIFE INC.——
1355NEOGENOMICS INC—$500K
1356VIVARAY INC—$600K
1357Sonendo, Inc.—$238M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.